HOWL — Werewolf Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1785530 ·
Last close
$1.05
Market Cap
$51.03M
52W High
$1.20
52W Low
$0.27
ADV30
400,435
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -10,054,000 | -9,877,000 | 42,753,000 | 41,870,000 | 35,994,000 |
| Jun 2026 | 21,000,000 | — | 7,158,000 | 3,670,000 | 24,155,000 | 21,987,000 | 7,863,000 |
| Mar 2026 | 0 | — | -13,271,000 | -13,532,000 | 58,022,000 | 46,450,000 | 45,820,000 |
| Dec 2025 | 0 | — | -9,418,000 | -8,381,000 | 69,396,000 | 57,050,000 | 44,591,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,148,000
Investing CF
$0
Financing CF
$6,028,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.76
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-485,272,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-30,060,000
Pretax Income TTM
$-34,613,000
Interest Exp TTM
$4,553,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$21,000,000
EBITDA
$-21,921,000
Free Cash Flow
$-12,233,750
Enterprise Value
$25,654,664
Total Cash
$21,987,000
Total Debt
$0
Shares Out
48,599,066
Trailing EPS
$-0.73
Book Value
$0.34
ROE
-119.9%
ROA
-27.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -60,677,000 | -60,822,000 | 69,396,000 | 44,591,000 | 24,805,000 | -60,292,000 |
| Dec 2024 | 1,885,000 | -73,594,000 | -70,515,000 | 126,929,000 | 53,539,000 | 73,390,000 | -56,188,000 |
| Dec 2023 | 19,943,000 | -40,503,000 | -37,368,000 | 174,833,000 | 63,459,000 | 111,374,000 | -32,612,000 |
| Dec 2022 | 16,401,000 | -56,056,000 | -53,810,000 | 160,245,000 | 37,908,000 | 122,337,000 | -40,596,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$1,971,000
NetIncome TTM
$-34,613,000
OpCashFlow TTM
—
Assets (Latest)
$24,155,000
Forward EPS
$-0.59
Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.00 · spot: $1.03 · call volume: 10 · put volume: 32
Expected Move to 2027-04-16:
±$0.95
(92.23%) —
implied range
$0.08 –
$1.98
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc. | $51.44M | $0.41 | — |
| ONCY | ONCOLYTICS BIOTECH INC | $50.15M | $0.38 | — |
| PDSB | PDS Biotechnology Corp | $50.03M | $0.89 | — |
| AZR | Azora Therapeutics, Inc. (DE) | $52.36M | $3.66 | — |
| SPRO | Spero Therapeutics, Inc. | $52.51M | $0.90 | — |
News headlines (Yahoo Finance, 1h cache)
Werewolf Therapeutics’ Clinical Data for WTX-124 and WTX-330 Presented at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting
2026-11-09 13:30 · Yahoo
Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting
2026-10-30 12:30 · Yahoo
Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why
2026-10-13 15:00 · Yahoo
New Strong Buy Stocks for October 9th
2026-10-09 09:46 · Yahoo
1 Penny Stock That Could Howl Its Way to the Top After a $150 Million Funding Boost
2026-08-26 15:47 · Yahoo
Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News
2026-08-21 17:51 · Yahoo
Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million financing
2026-08-21 13:26 · Yahoo
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
2026-08-21 12:00 · Yahoo
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
2026-07-31 11:00 · Yahoo
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
2026-05-07 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.